Furthermore, an analysis of publicly available single-cell RNA sequencing data from COVID-19 patients revealed increased gene expressions of CD25 and CD132 but not CD122 in basophils from severe patients, which is associated with higher levels of IL-3 and IL-33, positioning CD25 on basophils as one of the potential biomarkers for severe COVID-19. This evidence concerns the gene IL2RA and COVID-19.